Our Science

Powerful innovation to transform MS

We're committed to rigorous and ongoing evaluation.

Investigation of Serum Based Proteomic Biomarker Signatures Relative to Steroid Responsiveness and Disease Activity Status in Relapsing Multiple Sclerosis Patients

Multivariate Proteomic MS Disease Activity Test Results Surfaces Both Individual Patient and Clinical Practice Population Insights

Multivariate Proteomic MS Disease Activity Test Score Performance Evaluated in an Independent Focal Inflammation Cohort

Accounting for Variance in Brain Atrophy Measurements by Quantifying Image Quality Differences across Longitudinal Imaging Studies

Multivariate Proteomic MS Disease Activity Test Results Surfaces Both Individual Patient and Clinical Practice Population Insights

Association Between Serum Biomarkers and Patient-Reported Outcome of Disability in Multiple Sclerosis

Analytical Validation of the Disease Activity Score and 4 Disease Pathway Scores for a Multivariate Proteomic Multiple Sclerosis Disease Activity Test

Multivariate Proteomic MS Disease Activity Test Result Distributions Based on Disease Modifying Therapy Categories

Estimation of Disability Status from Blood Serum Protein Concentrations

Clinical Validation Study Results for a Multivariate Proteomic MS Disease Activity Test

1 … 6 7 8 9

Investigation of Serum Based Proteomic Biomarker Signatures Relative to Steroid Responsiveness and Disease Activity Status in Relapsing Multiple Sclerosis Patients

Multivariate Proteomic MS Disease Activity Test Results Surfaces Both Individual Patient and Clinical Practice Population Insights

Multivariate Proteomic MS Disease Activity Test Score Performance Evaluated in an Independent Focal Inflammation Cohort

Accounting for Variance in Brain Atrophy Measurements by Quantifying Image Quality Differences across Longitudinal Imaging Studies

Multivariate Proteomic MS Disease Activity Test Results Surfaces Both Individual Patient and Clinical Practice Population Insights

Association Between Serum Biomarkers and Patient-Reported Outcome of Disability in Multiple Sclerosis

Analytical Validation of the Disease Activity Score and 4 Disease Pathway Scores for a Multivariate Proteomic Multiple Sclerosis Disease Activity Test

Multivariate Proteomic MS Disease Activity Test Result Distributions Based on Disease Modifying Therapy Categories

Estimation of Disability Status from Blood Serum Protein Concentrations

Clinical Validation Study Results for a Multivariate Proteomic MS Disease Activity Test